Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

NK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway.

Ge X, Wang Y, Li Q, Yu H, Ji G, Miao L.

Oncol Rep. 2013 Jul;30(1):448-54. doi: 10.3892/or.2013.2427. Epub 2013 Apr 25.

PMID:
23619566
[PubMed - indexed for MEDLINE]
2.

NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.

Ge X, Wang Y, Wang Y, Li Q, Yu H, Miao L.

Dig Dis Sci. 2013 Jun;58(6):1636-43. doi: 10.1007/s10620-012-2523-7. Epub 2013 Jan 12.

PMID:
23314853
[PubMed - indexed for MEDLINE]
3.

NK4 gene expression enhances 5-fluorouracil-induced apoptosis of murine colon cancer cells.

Taiyoh H, Kubota T, Fujiwara H, Matsumura A, Murayama Y, Okamoto K, Ichikawa D, Ochiai T, Nakamura T, Matsumoto K, Nakamura T, Otsuji E.

Anticancer Res. 2011 Jun;31(6):2217-24.

PMID:
21737644
[PubMed - indexed for MEDLINE]
4.

Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil.

Hahnvajanawong C, Chaiyagool J, Seubwai W, Bhudhisawasdi V, Namwat N, Khuntikeo N, Sripa B, Pugkhem A, Tassaneeyakul W.

World J Gastroenterol. 2012 Aug 14;18(30):3955-61. doi: 10.3748/wjg.v18.i30.3955.

PMID:
22912546
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Consensus interferon enhances the anti-proliferative effect of 5-fluorouracil on human hepatoma cells via downregulation of dihydropyrimidine dehydrogenase expression.

Dou J, Iwashita Y, Sasaki A, Kai S, Hirano S, Ohta M, Kitano S.

Liver Int. 2005 Feb;25(1):148-52.

PMID:
15698412
[PubMed - indexed for MEDLINE]
6.

The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells.

Oguri T, Achiwa H, Bessho Y, Muramatsu H, Maeda H, Niimi T, Sato S, Ueda R.

Lung Cancer. 2005 Sep;49(3):345-51.

PMID:
15993511
[PubMed - indexed for MEDLINE]
7.

Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met.

Leelawat K, Leelawat S, Tepaksorn P, Rattanasinganchan P, Leungchaweng A, Tohtong R, Sobhon P.

J Surg Res. 2006 Nov;136(1):78-84. Epub 2006 Sep 1.

PMID:
16950403
[PubMed - indexed for MEDLINE]
8.

Apoptosis of human cholangiocarcinoma cell lines induced by β-escin through mitochondrial caspase-dependent pathway.

Shen DY, Kang JH, Song W, Zhang WQ, Li WG, Zhao Y, Chen QX.

Phytother Res. 2011 Oct;25(10):1519-26. doi: 10.1002/ptr.3435. Epub 2011 Mar 11.

PMID:
21394804
[PubMed - indexed for MEDLINE]
9.

Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.

Okumura K, Shiomi H, Mekata E, Kaizuka M, Endo Y, Kurumi Y, Tani T.

Oncol Rep. 2006 Apr;15(4):875-82.

PMID:
16525674
[PubMed - indexed for MEDLINE]
10.

Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines.

Ando T, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Sugito N, Mori R, Ogawa R, Katada T, Fujii Y.

Dis Esophagus. 2008;21(1):15-20. doi: 10.1111/j.1442-2050.2007.00700.x.

PMID:
18197934
[PubMed - indexed for MEDLINE]
11.

Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine.

Ma T, Zhu ZG, Ji YB, Zhang Y, Yu YY, Liu BY, Yin HR, Lin YZ.

World J Gastroenterol. 2004 Jan 15;10(2):172-6.

PMID:
14716816
[PubMed - indexed for MEDLINE]
Free Article
12.

Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines.

Miyazaki K, Shibahara T, Sato D, Uchida K, Suzuki H, Matsui H, Yanaka A, Nakahara A, Matsuzaki Y.

J Gastroenterol. 2006 Feb;41(2):140-50.

PMID:
16568373
[PubMed - indexed for MEDLINE]
13.

Calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal cancer by modulating the intrinsic apoptotic pathway.

Stevenson L, Allen WL, Proutski I, Stewart G, Johnston L, McCloskey K, Wilson PM, Longley DB, Johnston PG.

PLoS One. 2011;6(5):e20276. doi: 10.1371/journal.pone.0020276. Epub 2011 May 24.

PMID:
21629658
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma.

Shen DY, Zhang W, Zeng X, Liu CQ.

Cancer Sci. 2013 Oct;104(10):1303-8. doi: 10.1111/cas.12223. Epub 2013 Aug 6.

PMID:
23822562
[PubMed - indexed for MEDLINE]
15.

Relationship between gene expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in primary cancer cells isolated from malignant ascites.

Wang T, Wang L, Qian X, Yu L, Ding Y, Liu B.

Cancer Invest. 2011 Feb;29(2):130-6. doi: 10.3109/07357907.2010.535060. Epub 2011 Jan 6.

PMID:
21210725
[PubMed - indexed for MEDLINE]
16.

Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.

Kim R, Tanabe K, Inoue H, Toge T.

Int J Oncol. 2002 Mar;20(3):549-55.

PMID:
11836567
[PubMed - indexed for MEDLINE]
17.

Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.

Suzuki Y, Sakai K, Ueki J, Xu Q, Nakamura T, Shimada H, Nakamura T, Matsumoto K.

Int J Cancer. 2010 Oct 15;127(8):1948-57. doi: 10.1002/ijc.25197.

PMID:
20104519
[PubMed - indexed for MEDLINE]
18.

Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.

Gu W, Fang FF, Li B, Cheng BB, Ling CQ.

Asian Pac J Cancer Prev. 2012;13(9):4807-14.

PMID:
23167424
[PubMed - indexed for MEDLINE]
Free Article
19.

Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.

Bras-Gonçalves RA, Pocard M, Formento JL, Poirson-Bichat F, De Pinieux G, Pandrea I, Arvelo F, Ronco G, Villa P, Coquelle A, Milano G, Lesuffleur T, Dutrillaux B, Poupon MF.

Gastroenterology. 2001 Mar;120(4):874-88.

PMID:
11231942
[PubMed - indexed for MEDLINE]
20.

The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.

Jiang H, Dong Q, Luo X, Shi B, Wang H, Gao H, Kong J, Zhang J, Li Z.

Cancer Lett. 2014 Jan 1;342(1):113-20. doi: 10.1016/j.canlet.2013.08.038. Epub 2013 Sep 2.

PMID:
24007863
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk